Lebwohl David - Insider Non-Derivative Transactions at Intellia Therapeutics, Inc. (NTLA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 1, 2024, Lebwohl David's relationship to Intellia Therapeutics, Inc. (NTLA) is Officer (EVP, Chief Medical Officer), and currently has 93,073 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NTLA insiders.
Data Source: SEC.
Lebwohl David - Insider Non-Derivative Transactions of NTLA Common Stock
Lebwohl David - Insider Non-Derivative Transactions at NTLA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 2, 2024 | Acquisition -- (Common Stock) | 38701 | 0 | 93073 |
| Jan 4, 2024 | Sell -- (Common Stock) | 5843 | 29.46 | 54372 |
| Jan 2, 2024 | M -- (Common Stock) | 3187 | 0 | 60215 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 30674 | 0 | 56361 |
| Jan 5, 2023 | Sell -- (Common Stock) | 2574 | 37.21 | 25687 |
| Jan 2, 2023 | M -- (Common Stock) | 3187 | 0 | 28261 |